1. Home
  2. TKNO

as 07-26-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

Founded: 1996 Country:
United States
United States
Employees: N/A City: HOLLISTER
Market Cap: 71.8M IPO Year: 2021
Target Price: $5.00 AVG Volume (30 days): 1.5M
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.04 EPS Growth: N/A
52 Week Low/High: $1.16 - $4.27 Next Earning Date: 08-13-2024
Revenue: $36,853,000 Revenue Growth: -6.45%
Revenue Growth (this year): 3.81% Revenue Growth (next year): 23.58%

TKNO Daily Stock ML Predictions

Stock Insider Trading Activity of Alpha Teknova Inc. (TKNO)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Grossman Paul David TKNO Director Aug 15 '22 Buy $5.15 4,826 $24,843.28 4,826 SEC Form 4
Grossman Paul David TKNO Director Aug 15 '22 Buy $5.62 4,386 $24,660.72 9,212 SEC Form 4

Share on Social Networks: